News

Angitia Biopharmaceuticals to Showcase Innovations at Conference

Angitia Biopharmaceuticals to Showcase Innovations at Conference

Angitia Biopharmaceuticals to Present at Major Conference

WOODLAND HILLS, Calif. — Angitia Biopharmaceuticals, a pioneering clinical-stage biotechnology company, is gearing up to present its groundbreaking advancements at the 43rd Annual J.P. Morgan Healthcare Conference. This significant event is scheduled to take place in January, showcasing the latest developments in healthcare innovations.

Event Details

David Ke, M.D., the Chief Executive Officer of Angitia, will take center stage during the conference to discuss the company’s strategic vision and innovative therapies. The specifics of the presentation are as follows:

  • Conference: 43rd Annual J.P. Morgan Healthcare Conference
  • Date: January 13, 2025
  • Time: 9:30 – 9:55 AM PT
  • Presenter: David Ke, M.D.
  • Location: Mission Bay Room, The Westin St. Francis Hotel

Understanding Angitia Biopharmaceuticals

Angitia Biopharmaceuticals is committed to advancing the field of biotechnology with a focus on developing innovative therapeutics that specifically target serious musculoskeletal conditions. With a strong research background, Angitia is dedicated to finding solutions for conditions such as osteoporosis and osteogenesis imperfecta, contributing significantly to unmet medical needs within this sector.

Innovative Product Pipeline

The company is currently exploring three biologic product candidates aimed at revolutionizing the treatment of osteoporosis, osteogenesis imperfecta, and spinal fusion procedures. Each candidate benefits from Angitia's team's wealth of experience and scientific insight, underscoring their commitment to excellence in drug development.

Company Mission and Vision

Angitia's mission revolves around leveraging its expertise to provide effective therapies that significantly improve patients' quality of life. By focusing on innovative treatment options, Angitia aims to fulfill critical healthcare gaps that exist today, ensuring that patients have access to the therapies they desperately need.

Contact Angitia for More Information

For media inquiries or more information about Angitia’s presentation and initiatives, interested parties can reach out to:

William Windham
Solebury Strategic Communications
Email: wwindham@soleburystrat.com
Phone: 646-378-2946

Frequently Asked Questions

What is the purpose of the J.P. Morgan Healthcare Conference?

The J.P. Morgan Healthcare Conference is held annually to showcase innovations in healthcare and biotechnology, connecting industry leaders and investors.

Who will be presenting for Angitia Biopharmaceuticals?

David Ke, M.D., the CEO of Angitia Biopharmaceuticals, will present the company's strategic vision and product developments.

What diseases is Angitia focused on treating?

Angitia is focused on developing therapies for serious musculoskeletal diseases, primarily osteoporosis and osteogenesis imperfecta.

How does Angitia approach drug development?

Angitia emphasizes innovative research combined with extensive scientific experience to develop effective therapies addressing unmet medical needs.

How can investors or media contact Angitia?

Investors and media inquiries can contact William Windham at Solebury Strategic Communications via email or phone for more information.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Lode Gold Explores Fremont's Untapped Gold Potential

Updated Category News Views 81

Reviving an Old Gold Story The charm of Fremont Gold Mine lies in its history as much as it does in its potential. Lode Gold Resources Inc., that old miner itching to strike gold like it's 1849 all over again, has set its sights on reevaluating the treasure trove beneath Mariposa County, California. Exploration efforts are charging ahead to uncover whether this mine still...

Continue Reading
It'Sugar Faces Class Action Over Employee Break Violations

Updated Category News Views 50

It'Sugar Faces Class Action Over Employee Rights Looks like the sugar rush turned into a legal headache for It'Sugar, a renowned candy retailer, as they're now tangled up in a class action lawsuit. This one's not just about spilled sprinkles—it's about alleged deep-rooted violations of California's labor laws. The Zakay Law Group, a labor law outfit outta San Diego, has...

Continue Reading
ROKAE Hits 10,000 Delivery Mark for Robotic Arms

Updated Category News Views 167

ROKAE's Big 10K: A Milestone Worth Noting Alright, if you've been around the block as long as I have, you know the robotics game isn't just about making cool gadgets—it's about hitting those serious deployment numbers. ROKAE Robotics just rolled its 10,000th humanoid force-controlled arm off the line in Shandong, and this ain't just another notch on their belt. This...

Continue Reading
Bladex Declares Quarterly Dividend for Q3 2026

Updated Category News Views 41

Bladex's Steady Dividend: What's Under the Hood? Well, well, it looks like Bladex is doing the old dividend dance again. They've just announced a quarterly cash dividend of $0.6875 per share for the third quarter of 2026. It's scheduled for payout on November 24 to those who have their noses in the ledger come November 6—that's your record date, folks. Now, dividends...

Continue Reading
Zinzino Eyes European Market With New Botanical Line

Updated Category News Views 132

Zinzino's Strategic Play in Europe's Wellness Market There's a new player on the European wellness block, and it's Zinzino's latest concoction of fermented botanical supplements. This isn't just your run-of-the-mill vitamin shop stock; we're talking about a lineup crafted for distinct parts of the day, reflecting an evolving consumer trend. People are looking for tailored...

Continue Reading
Greenhouse and Planetarium Revamp Enrich Florida Southern

Updated Category News Views 38

A Celebration of Science and Heritage In an era where institutions are either scaling back or going digital, Florida Southern College is doubling down on its roots and looking skyward. On October 22, 2026, the campus buzzed with a celebration that would have done any investor in education and heritage proud—raising the Ben and Missy Albritton Citrus and Horticulture...

Continue Reading
Epic Oceanside Estate Set for No-Reserve Luxury Auction

Updated Category News Views 66

Going, Going, Gone? A Golf Exec's Dream Home What's hotter than Florida's summer sun? It's this swanky estate at Ponte Vedra Beach set to hit the auction block without any safety net. Yup, no reserve, folks! Leonard "Len" Brown, Jr., the brains behind many of PGA Tour's global ventures, has decided to put his lavish 3.2-acre plot right by the ocean up for grabs. Once...

Continue Reading
Century Communities Unveils New Homes Near Austin

Updated Category News Views 135

New Opportunities in the Lone Star State Century Communities, Inc. (NYSE: CCS) is cranking up the heat in the real estate market with their latest attraction—Crosswinds in Kyle, Texas. This isn't just another cookie-cutter development; it's packing in excitement with a grand opening on October 28. From model home tours to early-bird savings, they're pulling out all the...

Continue Reading
Teamsters Secure Strong Contract for CA Waste Workers

Updated Category News Views 63

Teamsters Flex Muscles in So-Cal Sanitation Sector So here's one for the books: 700 Waste Management workers represented by Teamsters Local 396 just locked down a fresh collective bargaining agreement in Los Angeles and Orange counties. And let me tell you, this isn’t just another contract—it's a testament to what solidarity can wring out of a massive corporation. The...

Continue Reading
E-Filing: Why Ditching IRS Paper Forms Matters Now

Updated Category News Views 153

Tax Filing Today: The Old vs. The New Listen up, tax-filing warriors. Tackling that IRS Form 941 deadline isn’t just another play in the small business game—it’s crunch time. November 2, 2026, isn’t waiting around for excuses. Luckily, Halfpricesoft.com just chucked you a lifeline with their updated ezPaycheck platform. Swap that mountain of mangled paper forms...

Continue Reading

Top 5 Most Recently Viewed Articles

Avery Dennison Corporation: Strong Earnings Forecast and Growth

Updated Category News Views 96

Avery Dennison Corporation's Promising Growth Potential Avery Dennison Corporation (NYSE: AVY) is a notable player in the material science sector, focusing on labeling and packaging solutions. The company recently attracted attention from Barclays, which has issued an 'Overweight' rating on its stock, accompanied by a price target set at $250. This assessment signifies...

Continue Reading
Understanding AMMO, Inc. Legal Rights for Investors Amid Losses

Updated Category News Views 158

AMMO, Inc. Investor Update: Legal Rights and Options Investors in AMMO, Inc. face a challenging time as the company's recent disclosures raise concerns about its internal financial controls. A recent investigation has been initiated by Faruqi & Faruqi, LLP, a national law firm specializing in securities litigation, which may affect investor positions. If you have...

Continue Reading
Strengthening the Future: Renew's Leadership Expansion Efforts

Updated Category News Views 162

Renew's Leadership Boost: Key Hires for Growth Renew, a trailblazer in the real estate industry known for its unique renewal and retention management platform, has recently bolstered its leadership team. This strategic enhancement comes with the addition of two seasoned executives, aimed at accelerating growth and fostering deeper customer interactions. Powerful New...

Continue Reading
Inflation Data Shifts Crypto Markets as Bitcoin Leads Report Insights

Updated Category News Views 193

Inflation Data and Its Impact on the Crypto Market The U.S. Commerce Department recently announced that the key inflation rate slightly increased, which sent waves across the crypto markets. The inflation rate for September edged up to 2.1%, moving closer to the target set by the Federal Reserve. Investors are carefully analyzing this information, particularly as it...

Continue Reading
Fulcrum's Pociredir Halt? Investors Reeling After FDA Blow

Updated Category News Views 9

Fulcrum's Tumultuous Turn June's supposed summer warmth brought a chill to Fulcrum Therapeutics' investors as a severe plunge shook NASDAQ:FULC to its core. One isn't surprised that Levi & Korsinsky is sniffing around, seeing potential treachery afoot. The pot boiled over after Fulcrum disclosed the discontinuation of pociredir—it's enough to send anyone's blood...

Continue Reading